We tested the effects of MEDS-23 on levels of IL-6, PGE2 and TNF-α in the brains of post-stroke rats to elucidate whether it exerts anti-inflammatory effects that may explain its ability to alleviate the elevated BT (fever) observed in these animals. This evidence concerns the gene TNF and stroke disorder.